ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · IEX Real-Time Price · USD
8.02
+0.05 (0.63%)
Mar 27, 2023, 4:30 PM EDT - Market closed
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 197 | 208 | 265 | 268 | 73 | 17 | 29 | 12 | 28 | 49 | 85 | |
| Market Cap Growth | - | -21.59% | -1.05% | 267.26% | 337.08% | -41.62% | 133.00% | -56.91% | -41.81% | -42.27% | 10.39% | |
| Enterprise Value | 172 | 182 | 223 | 272 | 70 | 17 | 24 | 13 | 31 | 47 | 90 | |
| PE Ratio | -12.65 | -12.65 | -18.41 | -39.52 | -13.17 | -2.71 | -3.99 | -1.52 | -3.37 | -10.82 | -11.97 | |
| PS Ratio | 9.60 | 10.12 | 16.27 | 20.90 | 6.51 | 2.27 | 3.88 | 2.13 | 6.20 | 13.58 | 21.58 | |
| PB Ratio | 5.35 | 5.64 | 5.44 | 112.77 | 15.92 | 11.05 | 4.91 | -16.24 | -14.38 | -487.98 | -12.41 | |
| P/FCF Ratio | -12.01 | -12.01 | -20.62 | -32.34 | -24.25 | -3.56 | -4.75 | -2.07 | -3.27 | -6.71 | -10.80 | |
| P/OCF Ratio | -12.86 | -12.86 | -20.89 | -34.34 | -25.61 | -3.61 | -4.77 | -2.11 | -3.30 | -6.75 | -10.90 | |
| EV/Sales Ratio | 8.36 | 8.88 | 13.71 | 21.21 | 6.22 | 2.32 | 3.28 | 2.34 | 6.75 | 13.15 | 22.82 | |
| EV/EBITDA Ratio | -11.71 | -11.71 | -17.53 | -56.82 | -16.10 | -3.37 | -3.92 | -1.96 | -4.45 | -15.15 | -14.56 | |
| EV/EBIT Ratio | -11.16 | -11.16 | -16.63 | -50.97 | -15.21 | -3.30 | -3.85 | -1.92 | -4.32 | -13.52 | -13.62 | |
| EV/FCF Ratio | -10.54 | -10.54 | -17.37 | -32.82 | -23.17 | -3.64 | -4.03 | -2.27 | -3.56 | -6.50 | -11.43 | |
| Debt / Equity Ratio | 0.32 | 0.32 | 0.25 | 10.15 | 0.54 | 2.30 | 0.84 | -5.94 | -4.01 | -76.65 | -1.23 | |
| Debt / EBITDA Ratio | -0.77 | -0.77 | -0.96 | -5.04 | -0.57 | -0.69 | -0.80 | -0.65 | -1.14 | -2.46 | -1.37 | |
| Debt / FCF Ratio | -0.69 | -0.69 | -0.95 | -2.91 | -0.82 | -0.74 | -0.82 | -0.76 | -0.91 | -1.05 | -1.07 | |
| Current Ratio | 7.54 | 7.54 | 13.02 | 7.96 | 2.71 | 3.56 | 2.90 | 2.02 | 1.12 | 2.38 | 0.59 | |
| Asset Turnover | 0.35 | 0.35 | 0.23 | 0.52 | 0.97 | 0.73 | 0.56 | 0.74 | 0.53 | 0.38 | 0.38 | |
| Return on Equity (ROE) | -39.80% | -39.80% | -31.20% | -409.40% | -123.50% | -200.20% | -147.50% | 416.00% | 195.20% | 115.50% | 165.40% | |
| Return on Assets (ROA) | -27.90% | -27.90% | -20.50% | -27.70% | -48.00% | -60.90% | -54.70% | -103.60% | -97.10% | -47.10% | -68.50% | |
| Return on Capital (ROIC) | -47.70% | -47.70% | -52.50% | -24.00% | -92.50% | -116.90% | -128.40% | -118.80% | -190.50% | -60.30% | -143.90% | |
| Earnings Yield | -8.33% | -7.90% | -5.43% | -2.53% | -7.59% | -36.91% | -25.06% | -65.74% | -29.66% | -9.24% | -8.36% | |
| FCF Yield | -8.77% | -8.32% | -4.85% | -3.09% | -4.12% | -28.11% | -21.04% | -48.23% | -30.59% | -14.91% | -9.26% | |
| Buyback Yield / Dilution | -16.63% | -16.63% | -30.82% | -20.48% | -20.38% | -41.22% | -180.90% | -46.16% | -27.27% | -3.46% | -41.83% | |
| Total Shareholder Return | -16.63% | -16.63% | -30.82% | -20.48% | -20.38% | -41.22% | -180.90% | -46.16% | -27.27% | -3.46% | -41.83% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).